South West Sydney Clinical Campuses

Karimi N; Sechi AJ; Harb M; Sawyer E; Williams AJ; Ng W; Connor SJ, 2021, 'The effect of a nurse-led advice line and virtual clinic on inflammatory bowel disease service delivery: an Australian study', European journal of gastroenterology & hepatology, vol. 33, pp. e771 - e776, http://dx.doi.org/10.1097/MEG.0000000000002249

Dubinsky MC; Watanabe K; Molander P; Peyrin-Biroulet L; Rubin M; Melmed GY; Deuring JJ; Woolcott J; Cappelleri JC; Steinberg K; Connor S, 2021, 'Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living with Ulcerative Colitis-Patients' and Physicians' View', Inflammatory Bowel Diseases, vol. 27, pp. 1747 - 1755, http://dx.doi.org/10.1093/ibd/izab016

Connor SJ; Sechi A; Andrade M; Deuring JJ; Witcombe D, 2021, 'Ulcerative Colitis Narrative findings: Australian survey data comparing patient and physician disease management views', JGH Open, vol. 5, pp. 1033 - 1040, http://dx.doi.org/10.1002/jgh3.12627

Karimi N; Kanazaki R; Lukin A; Moore AR; Williams AJ; Connor S, 2021, 'Clinical communication in inflammatory bowel disease: A systematic review of the study of clinician-patient dialogue to inform research and practice', BMJ Open, vol. 11, http://dx.doi.org/10.1136/bmjopen-2021-051053

Crane H; Wu N; Chan P; Nguyen P; Williams A-J; Ng W; Connor SJ, 2021, 'Safety, satisfaction, and cost savings of accelerated infusions of standard and intensified-dose infliximab for inflammatory bowel disease.', Intern Med J, http://dx.doi.org/10.1111/imj.15493

Kaazan P; Li T; Seow W; Bednarz J; Pipicella JL; Krishnaprasad K; Ng W; Williams A-J; Connor SJ; Andrews JM, 2021, 'Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease', JGH OPEN, vol. 5, pp. 1063 - 1070, http://dx.doi.org/10.1002/jgh3.12631

Gu B; De Gregorio M; Pipicella JL; Vande Casteele N; Andrews JM; Begun J; Connell W; D'Souza B; Gholamrezaei A; Hart A; Liew D; Radford-Smith G; Rimola J; Sutherland T; Toong C; Woods R; Wu Y; Xuan W; Williams AJ; Ng W; Ding NS; Connor S, 2021, 'Prospective randomised controlled trial of adults with perianal fistulising Crohn's disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol', BMJ open, vol. 11, http://dx.doi.org/10.1136/bmjopen-2020-043921

Wu Y; Wen A; Selvanderan SP; Xuan W; Andrews JM; Koo JH; Williams AJ; Ng W; Connor S, 2021, 'Management Decisions in Crohn's Disease Are Changed by Knowledge of Proactive and Reactive Testing of Antitumor Necrosis Factor Drug Levels', Crohn's and Colitis 360, vol. 3, http://dx.doi.org/10.1093/crocol/otab042

De Gregorio M; Lee T; Krishnaprasad K; Amos G; An YK; Bastian-Jordan M; Begun J; Borok N; Brown DJM; Cheung W; Connor S; Gerstenmaier J; Gilbert LE; Gilmore R; Gu B; Kutaiba N; Lee A; Mahy G; Srinivasan A; Thin L; Thompson A; Welman CJ; Yong EX; De Cruz P; van Langenberg D; Sparrow co-lead senior author M; Ding NS, 2021, 'P399 Higher anti-tumour necrosis factor-alpha drug levels are associated with improved radiological outcomes in patients with perianal fistulising Crohn’s disease: A retrospective multi-centre study', Journal of Crohn's and Colitis, vol. 15, pp. S408 - S409, http://dx.doi.org/10.1093/ecco-jcc/jjab076.523

Kaazan P; Li T; Seow W; Bednarz J; Pipicella J; Ng W; Wiiliams AJ; Connor S; Andrews J, 2021, 'P232 Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease', Journal of Crohn's and Colitis, vol. 15, pp. S281 - S281, http://dx.doi.org/10.1093/ecco-jcc/jjab076.358

Wu Y; Lin B; Thilakanathan C; Lehmann P; Xuan W; Mohsen W; Toong C; Williams AJ; Ng W; Connor S, 2021, 'Therapeutic drug monitoring in inflammatory bowel disease reduces unnecessary use of infliximab with substantial associated cost-savings', Internal Medicine Journal, vol. 51, pp. 739 - 745, http://dx.doi.org/10.1111/imj.14644

Kanazaki R; Smith B; Girgis A; Descallar J; Connor S, 2021, 'Survey of barriers to adherence to international inflammatory bowel disease guidelines: Does gastroenterologists' confidence translate to high adherence?', Intern Med J, http://dx.doi.org/10.1111/imj.15299

Mohsen W; Williams AJ; Wark G; Sechi A; Koo JH; Xuan W; Bassan M; Ng W; Connor S, 2021, 'Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy?', World Journal of Gastroenterology, vol. 27, pp. 1090 - 1100, http://dx.doi.org/10.3748/wjg.v27.i11.1090

Williams AJ; Paramsothy R; Wu N; Ghaly S; Leach S; Paramsothy S; Corte C; O'Brien C; Burke C; Wark G; Samocha-Bonet D; Lambert K; Ahlenstiel G; Wasinger V; Dutt S; Pavli P; Grimm M; Lemberg D; Connor S; Leong R; Hold G, 2021, 'Australia IBD Microbiome (AIM) Study: protocol for a multicentre longitudinal prospective cohort study', BMJ open, vol. 11, pp. e042493, http://dx.doi.org/10.1136/bmjopen-2020-042493

Kim AH; Girgis A; De Cruz P; Siegel CA; Karimi N; Ruban SO; Sechi AJ; Watson Ng WS; Andrews JM; Connor SJ, 2021, 'Development and feasibility of a web-based decision aid for patients with ulcerative colitis: Qualitative pilot study', Journal of Medical Internet Research, vol. 23, pp. e15946, http://dx.doi.org/10.2196/15946

De Gregorio M; Lee T; Krishnaprasad K; Amos G; An YK; Bastian-Jordan M; Begun J; Borok N; Brown DJM; Cheung W; Connor SJ; Gerstenmaier J; Gilbert LE; Gilmore R; Gu B; Kutaiba N; Lee A; Mahy G; Srinivasan A; Thin L; Thompson AJ; Welman CJ; Yong EXZ; De Cruz P; van Langenberg D; Sparrow MP; Ding NS, 2021, 'Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn's Perianal Fistulas', Clinical Gastroenterology and Hepatology, http://dx.doi.org/10.1016/j.cgh.2021.07.053

Prentice RE; Rentsch C; Al-Ani AH; Zhang E; Johnson D; Halliday J; Bryant R; Begun J; Ward MG; Lewindon PJ; Connor SJ; Ghaly S; Christensen B, 2021, 'SARS-CoV-2 vaccination in patients with inflammatory bowel disease.', GastroHep, vol. 3, pp. 212 - 228, http://dx.doi.org/10.1002/ygh2.473

Connor S, 2021, 'Biologics in IBD', Pathology, vol. 53, pp. S16 - S16, http://dx.doi.org/10.1016/j.pathol.2021.05.057

Connor S, 2021, 'Biologics in IBD', Pathology, vol. 53, pp. S5 - S5, http://dx.doi.org/10.1016/j.pathol.2021.05.017

Sam MJ; Connor SJ; Ng WWS; Toong CML, 2020, 'Comparative Evaluation of 4 Commercially Available ELISA Kits for Measuring Adalimumab and Anti-adalimumab Antibodies', Therapeutic Drug Monitoring, vol. 42, pp. 821 - 828, http://dx.doi.org/10.1097/FTD.0000000000000795

Krishnaprasad K; Walsh A; Begun J; Bell S; Carter D; Grafton R; Sechi A; Sewell K; McMahon A; Connor S; Radford-Smith G; Andrews JM, 2020, 'Crohn’s Colitis Care (CCCare): bespoke cloud-based clinical management software for inflammatory bowel disease', Scandinavian Journal of Gastroenterology, vol. 55, pp. 1419 - 1426, http://dx.doi.org/10.1080/00365521.2020.1839960

Karimi N; Moore AR; Lukin A; Kanazaki R; Williams AJ; Connor S, 2020, 'Clinical communication in inflammatory bowel disease: A systematic literature review protocol', BMJ Open, vol. 10, pp. e039503, http://dx.doi.org/10.1136/bmjopen-2020-039503

Reddy Pulusu SS; Srinivasan A; Krishnaprasad K; Cheng D; Begun J; Keung C; Van Langenberg D; Thin L; Mogilevski T; de Cruz P; Radford-Smith G; Flanagan E; Bell S; Kashkooli S; Sparrow M; Ghaly S; Bampton P; Sawyer E; Connor S; Rizvi QUA; Andrews JM; Mahy G; Chivers P; Travis S; CraigLawrance I, 2020, 'Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford', World Journal of Gastroenterology, vol. 26, pp. 4428 - 4441, http://dx.doi.org/10.3748/WJG.V26.I30.4428

Kim AH; Girgis A; Karimi N; Sechi AJ; Descallar J; Andrews JM; Siegel CA; Connor SJ, 2020, 'A web-based decision aid (myAID) to enhance quality of life, empowerment, decision making, and disease control for patients with ulcerative colitis: Protocol for a cluster randomized controlled trial', JMIR Research Protocols, vol. 9, http://dx.doi.org/10.2196/15994

Aysha AA; Rentsch C; Prentice R; Johnson D; Bryant RV; Ward MG; Costello SP; Lewindon P; Ghaly S; Connor SJ; Begun J; Christensen B, 2020, 'Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty', Internal Medicine Journal, vol. 50, pp. 798 - 804, http://dx.doi.org/10.1111/imj.14889

Haifer C; Kelly CR; Paramsothy S; Andresen D; Papanicolas LE; McKew GL; Borody TJ; Kamm M; Costello SP; Andrews JM; Begun J; Chan HT; Connor S; Ghaly S; Johnson PDR; Lemberg DA; Paramsothy R; Redmond A; Sheorey H; Van Der Poorten D; Leong RW, 2020, 'Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice', Gut, vol. 69, pp. 801 - 810, http://dx.doi.org/10.1136/gutjnl-2019-320260

Gardiner FW; Bishop L; McMahon K; Nwose EU; Connor S; Begun J; Andrews JM, 2020, 'Aeromedical retrievals for gastrointestinal disorders in rural and remote Australia: the need for improved access to specialist advice', Internal Medicine Journal, vol. 50, pp. 619 - 623, http://dx.doi.org/10.1111/imj.14822

Benson MJ; Abelev SV; Corte CJ; Connor SJ; McGregor IS, 2020, 'Attitudes and knowledge of australian gastroenterologists around the use of medicinal cannabis for inflammatory bowel disease', Crohn's and Colitis 360, vol. 2, http://dx.doi.org/10.1093/crocol/otaa045

Benson MJ; Abelev SV; Connor SJ; Corte CJ; Martin LJ; Gold LK; Suraev AS; McGregor IS, 2020, 'Medicinal cannabis for inflammatory bowel disease: A survey of perspectives, experiences, and current use in australian patients', Crohn's and Colitis 360, vol. 2, http://dx.doi.org/10.1093/crocol/otaa015

Julsgaard M; Hvas CL; Gearry RB; Gibson PR; Fallingborg J; Sparrow MP; Bibby BM; Connell WR; Brown SJ; Kamm MA; Lawrance IC; Vestergaard T; Svenningsen L; Baekdal M; Kammerlander H; Walsh A; Boysen T; Bampton P; Radford-Smith G; Kjeldsen J; Andrews JM; Subramaniam K; Moore GT; Jensen NM; Connor SJ; Wildt S; Wilson B; Ellard K; Christensen LA; Bell SJ, 2020, 'Anti-TNF Therapy in Pregnant Women with Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes', Inflammatory Bowel Diseases, vol. 26, pp. 93 - 102, http://dx.doi.org/10.1093/ibd/izz110

Flanagan E; Gibson PR; Wright EK; Moore GT; Sparrow MP; Connell W; Kamm MA; Begun J; Christensen B; De Cruz P; Shelton E; Dowling D; Andrews JM; Brown SJ; Niewiadomski O; Ward MG; Rosella O; Rosella G; Kiburg KV; Ross AL; Bell SJ; PICCOLO Study Group , 2020, 'Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure.', Aliment Pharmacol Ther, vol. 52, pp. 1551 - 1562, http://dx.doi.org/10.1111/apt.16102

Gu B; Venkatesh K; Williams A-J; Ng W; Corte C; Simon G; Xuan W; Paramsothy S; Connor SJ, 2020, 'Sa1891 HIGHER INFLIXIMAB AND ADALIMUMAB TROUGH LEVELS ARE ASSOCIATED WITH FISTULA HEALING IN PATIENTS WITH FISTULISING PERIANAL CROHN'S DISEASE', Gastroenterology, vol. 158, http://dx.doi.org/10.1016/s0016-5085(20)31850-3

Little RD; Chu IE; Van Der Zanden EP; Flanagan E; Bell SJ; Gibson PR; Sparrow MP; Shelton E; Connor SJ; Roblin X; Ward MG, 2019, 'Comparison of Adalimumab Serum Drug Levels When Delivered by Pen Versus Syringe in Patients with Inflammatory Bowel Disease. An International, Multicentre Cohort Analysis', Journal of Crohn's and Colitis, vol. 13, pp. 1527 - 1536, http://dx.doi.org/10.1093/ecco-jcc/jjz103

An YK; Prince D; Gardiner F; Neeman T; Linedale EC; Andrews JM; Connor S; Begun J, 2019, 'Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta-analysis', Medical Journal of Australia, vol. 211, pp. 461 - 467, http://dx.doi.org/10.5694/mja2.50384

Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO, 2019, 'Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis', Gastroenterology, vol. 156, pp. 1440 - 1454.e2, http://dx.doi.org/10.1053/j.gastro.2018.12.001

Walker GJ; Harrison JW; Heap GA; Voskuil MD; Andersen V; Anderson CA; Ananthakrishnan AN; Barrett JC; Beaugerie L; Bewshea CM; Cole AT; Cummings FR; Daly MJ; Ellul P; Fedorak RN; Festen EAM; Florin TH; Gaya DR; Halfvarson J; Hart AL; Heerasing NM; Hendy P; Irving PM; Jones SE; Koskela J; Lindsay JO; Mansfield JC; McGovern D; Parkes M; Pollok RCG; Ramakrishnan S; Rampton DS; Rivas MA; Russell RK; Schultz M; Sebastian S; Seksik P; Singh A; So K; Sokol H; Subramaniam K; Todd A; Annese V; Weersma RK; Xavier R; Ward R; Weedon MN; Goodhand JR; Kennedy NA; Ahmad T; Holden AL; Andrews J; Auth M; Babu S; Bampton P; Banim P; Barnes T; Basude D; Beckly J; Bell A; Bell S; Bhandari P; Bloom S; Border D; Bredin F; Brookes MJ; Brown M; Calvert C; Campbell D; Chanchlani N; Chaudhary B; Chaudhary R; Chung-Faye G; Colleypriest B; Connor S; Cooney R; Cooper S; Creed TJ; Croft N; Cullen S; D'Amato M; D'Inca R; Dalal H; Daneshmend TK; Das D; Delaney M; DeSilva S; Dhar A; Dharmasiri S; Direkze N; Dunckley P; Elphick D; Everett SM; Feeney M; Fell J; Foley S; Franke A; Gavin D; Gee I, 2019, 'Association of Genetic Variants in NUDT15 with Thiopurine-Induced Myelosuppression in Patients with Inflammatory Bowel Disease', JAMA - Journal of the American Medical Association, vol. 321, pp. 753 - 761, http://dx.doi.org/10.1001/jama.2019.0709

Schreiber S; Panaccione R; Kayhan C; Lopez-Sanroman A; Peyrin-Biroulet L; Armuzzi A; Dubinsky M; Melmed G; Rubin M; Connor S; Keefer L; Rubin DT, 2019, 'P023 PATIENT AND HEALTHCARE PROFESSIONAL VIEWS ON EMOTIONAL HEALTH AND INTIMACY IN ULCERATIVE COLITIS: RESULTS OF A GLOBAL ULCERATIVE COLITIS NARRATIVE SURVEY', Gastroenterology, vol. 156, pp. S17 - S17, http://dx.doi.org/10.1053/j.gastro.2019.01.072

Armuzzi A; Kayhan C; Panaccione R; Watanabe K; Molander P; Rubin DT; Peyrin-Biroulet L; Melmed G; Connor S; Colombel J-F; Dubinsky M, 2019, 'P005 DELAY IN DIAGNOSIS OF ULCERATIVE COLITIS: RESULTS OF A GLOBAL ULCERATIVE COLITIS NARRATIVE SURVEY', Gastroenterology, vol. 156, pp. S6 - S6, http://dx.doi.org/10.1053/j.gastro.2019.01.052

Liu F; Ma R; Tay CYA; Octavia S; Lan R; Chung HKL; Riordan SM; Grimm MC; Leong RW; Tanaka MM; Connor S; Zhang L, 2018, 'Genomic analysis of oral Campylobacter concisus strains identified a potential bacterial molecular marker associated with active Crohn's disease', Emerging Microbes and Infections, vol. 7, http://dx.doi.org/10.1038/s41426-018-0065-6

Connor S, 2018, 'What can Australian Inflammatory Bowel Disease Association achieve in the next 3 to 5 years?', Journal of Gastroenterology and Hepatology (Australia), vol. 33, pp. 35, http://dx.doi.org/10.1111/jgh.14437

Paramsothy S; Kamm M; Nielsen S; Deshpande N; Faith J; Clemente J; Paramsothy R; Walsh A; van den Bogaerde J; Samuel D; Leong R; Connor S; Ng W; Lin E; Wilkins M; Colombel J-F; Borody T; Mitchell H; Kaakoush N, 2018, 'OP019 In faecal microbiota transplantation (FMT) for ulcerative colitis, fusobacterium is associated with lack of remission, while metabolic shifts to starch degradation and short-chain fatty acid production are associated with remission (FOCUS study)', Journal of Crohn's and Colitis, vol. 12, pp. S013 - S014, http://dx.doi.org/10.1093/ecco-jcc/jjx180.018

Little R; Chu I; van der Zanden E; Flanagan E; Bell S; Sparrow M; Shelton E; Connor S; Roblin X; Ward M, 2018, 'P709 Is there a difference in adalimumab drug levels according to pen vs. syringe use: An international, multi-centre retrospective analysis', Journal of Crohn's and Colitis, vol. 12, pp. S469 - S470, http://dx.doi.org/10.1093/ecco-jcc/jjx180.836

Krishnaprasad K; Walsh A; Begun J; Bell S; Carter D; Grafton R; Sechi A; Sewell K; McMahon A; Connor S; Radford-Smith G; Andrews J, 2018, 'P328 Crohn’s colitis care (CCCare): development and testing of a bespoke cloud-based clinical management system for inflammatory bowel disease (IBD)', Journal of Crohn's and Colitis, vol. 12, pp. S266 - S268, http://dx.doi.org/10.1093/ecco-jcc/jjx180.455

Paramsothy S; Kamm MA; Nielsen S; Deshpande N; Faith J; Clemente JC; Paramsothy R; Walsh A; van den Bogaerde J; Samuel D; Leong RW; Connor SJ; Ng WSW; Lin E; Wilkins M; Colombel JF; Borody TJ; Mitchell HM; Kaakoush NO, 2018, '130 - In Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis, Fusobacterium is Associated with Lack of Remission, while Metabolic Shifts to Starch Degradation and Short Chain Fatty Acid Production are Associated with Remission – Results from the Randomized Controlled Focus Study', Gastroenterology, vol. 154, pp. S - 35, http://dx.doi.org/10.1016/s0016-5085(18)30588-2

Krishnaprasad K; Walsh A; Begun J; Bell S; Carter D; Grafton R; Sechi A; Sewell K; McMahon A; Connor SJ; Radford-Smith GL; Andrews JM, 2018, 'Tu1020 - Crohn's Colitis Care (CCcare) - Development and Testing of a Bespoke Cloud-Based Clinical Management System for Inflammatory Bowel Disease (IBD)', Gastroenterology, vol. 154, pp. S - 892, http://dx.doi.org/10.1016/s0016-5085(18)33012-9

Lord A; Mortlock S; Montgomery G; Simms L; Krishnaprasad K; Hanigan K; Doecke JD; Gearry R; Lawrance I; Bampton PA; Andrews JM; Mahy G; Connor SJ; Sparrow M; Bell S; Walsh A; Radford-Smith GL, 2018, 'Tu1807 - Genetically Distinct Signatures of Mild and Severe Ulcerative Colitis', Gastroenterology, vol. 154, pp. S - 1025, http://dx.doi.org/10.1016/s0016-5085(18)33433-4

Little RD; Chu IE; van der Zanden E; Flanagan E; Bell S; Sparrow M; Shelton E; Connor SJ; Roblin X; Ward MG, 2018, 'Mo1883 - Is There a Difference in Adalimumab Drug Levels According to Pen vs. Syringe use - An International, Multicenter Retrospective Analysis', Gastroenterology, vol. 154, http://dx.doi.org/10.1016/s0016-5085(18)32847-6

Mitrev N; Vande Casteele N; Seow CH; Andrews JM; Connor SJ; Moore GT; Barclay M; Begun J; Bryant R; Chan W; Corte C; Ghaly S; Lemberg DA; Kariyawasam V; Lewindon P; Martin J; Mountifield R; Radford-Smith G; Slobodian P; Sparrow M; Toong C; van Langenberg D; Ward MG; Leong RW, 2017, 'Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases', Alimentary Pharmacology and Therapeutics, vol. 46, pp. 1037 - 1053, http://dx.doi.org/10.1111/apt.14368

Aggarwal V; Day AS; Connor S; Leach ST; Brown G; Singh R; Friedman A; Zekry A; Craig PI, 2017, 'Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse', Gastrointestinal Endoscopy, vol. 86, pp. 1070 - 1078, http://dx.doi.org/10.1016/j.gie.2017.09.011

Bye WA; Sparrow MP; Connor SJ; Andrews JM; Ellard K; Ng W; Hume G; Antoniades S; Walsh AJ, 2017, 'The need for better preventative strategies for inflammatory bowel disease patients at risk of herpes zoster virus', Internal Medicine Journal, vol. 47, pp. 1263 - 1269, http://dx.doi.org/10.1111/imj.13488

Chen GB; Lee SH; Montgomery GW; Wray NR; Visscher PM; Gearry RB; Lawrance IC; Andrews JM; Bampton P; Mahy G; Bell S; Walsh A; Connor S; Sparrow M; Bowdler LM; Simms LA; Krishnaprasad K; Radford-Smith GL; Moser G, 2017, 'Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method', BMC Medical Genetics, vol. 18, http://dx.doi.org/10.1186/s12881-017-0451-2

Lawrance IC; Baird A; Lightower D; Radford-Smith G; Andrews JM; Connor S, 2017, 'Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis', Clinical Gastroenterology and Hepatology, vol. 15, pp. 1248 - 1255, http://dx.doi.org/10.1016/j.cgh.2017.02.027

Toong CML; Lee MWM; Connor S; Ng W, 2017, 'Response to: Comparison of infliximab drug measurement across three commercially available ELISA kits: author reply', Pathology, vol. 49, pp. 334 - 335, http://dx.doi.org/10.1016/j.pathol.2017.01.005

Paramsothy S; Kamm MA; Kaakoush NO; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Paramsothy R; Xuan W; Lin E; Mitchell HM; Borody TJ, 2017, 'Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial', The Lancet, vol. 389, pp. 1218 - 1228, http://dx.doi.org/10.1016/S0140-6736(17)30182-4

Doecke JD; Hartnell F; Bampton P; Bell S; Mahy G; Grover Z; Lewindon P; Jones LV; Sewell K; Krishnaprasad K; Prosser R; Marr D; Fischer J; R Thomas G; Tehan JV; Ding NS; Cooke SE; Moss K; Sechi A; De Cruz P; Grafton R; Connor SJ; Lawrance IC; Gearry RB; Andrews JM; Radford-Smith GL, 2017, 'Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study', Alimentary Pharmacology and Therapeutics, vol. 45, pp. 542 - 552, http://dx.doi.org/10.1111/apt.13880

Lawrance IC; Baird A; Lightowler D; Radford-Smith G; Andrews JM; Connor S, 2017, 'OP007 A multi-centre double blind randomised placebo-controlled study of the use of rectal tacrolimus in the treatment of resistant ulcerative proctitis', Journal of Crohn's and Colitis, vol. 11, pp. S4 - S5, http://dx.doi.org/10.1093/ecco-jcc/jjx002.006

Feagan BG; Sandborn WJ; Gasink C; Jacobstein D; Lang Y; Friedman JR; Blank MA; Johanns J; Gao LL; Miao Y; Adedokun OJ; Sands BE; Hanauer SB; Vermeire S; Targan S; Ghosh S; De Villiers WJ; Colombel JF; Tulassay Z; Seidler U; Salzberg BA; Desreumaux P; Lee SD; Loftus EV; Dieleman LA; Katz S; Rutgeerts P; Bampton P; Chung A; Connor S; Debinski H; Leong R; Macrae F; Pavli P; Sorrentino D; van den Bogaerde J; Vogel W; Vogelsang H; Louis E; Mana F; Zaltman C; Aumais G; Bernstein C; Bressler B; Dhalla S; Marshall J; Panaccione R; Ropeleski M; Stehlik J; Volfova M; Brynskov J; Glerup H; Abitbol-Selinger V; Allez M; Beaugerie L; Bourreille A; Cadiot G; Dupas J; Grimaud J; Laharie D; Lerebours E; Moreau J; Baumgart D; Brand S; Ebert M; Ehehalt R; Hasselblatt P; Howaldt S; Klaus J; Krummenerl P; Kucharzik T; Lügering A; Mudter J; Preiss J; Schreiber S; Stallmach A; Stein J; Strauch U; Salamon A; Patchett S; Lahat-Zok A; Rachmilewitz D; Annese V; Bossa F; Guidi L; Kohn A; Rocca R; Ando A; Ashida T; Hanai H; Ishida T; Ito H; Matsumoto T; Motoya S; Nakamura S; Sameshima Y; Suzuki Y; Watanabe K; Yamagami H; Yamamoto T, 2016, 'Ustekinumab as induction and maintenance therapy for Crohn's disease', New England Journal of Medicine, vol. 375, pp. 1946 - 1960, http://dx.doi.org/10.1056/NEJMoa1602773

Stein J; Connor S; Virgin G; Ong DEH; Pereyra L, 2016, 'Anemia and iron deficiency in gastrointestinal and liver conditions', World Journal of Gastroenterology, vol. 22, pp. 7908 - 7925, http://dx.doi.org/10.3748/wjg.v22.i35.7908

Chen JH; Andrews JM; Kariyawasam V; Moran N; Gounder P; Collins G; Walsh AJ; Connor S; Lee TWT; Koh CE; Chang J; Paramsothy S; Tattersall S; Lemberg DA; Radford-Smith G; Lawrance IC; McLachlan A; Moore GT; Corte C; Katelaris P; Leong RW, 2016, 'Review article: Acute severe ulcerative colitis - Evidence-based consensus statements', Alimentary Pharmacology and Therapeutics, vol. 44, pp. 127 - 144, http://dx.doi.org/10.1111/apt.13670

Julsgaard M; Christensen LA; Gibson PR; Gearry RB; Fallingborg J; Hvas CL; Bibby BM; Uldbjerg N; Connell WR; Rosella O; Grosen A; Brown SJ; Kjeldsen J; Wildt S; Svenningsen L; Sparrow MP; Walsh A; Connor SJ; Radford-Smith G; Lawrance IC; Andrews JM; Ellard K; Bell SJ, 2016, 'Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection', Gastroenterology, vol. 151, pp. 110 - 119, http://dx.doi.org/10.1053/j.gastro.2016.04.002

Connor SJ, 2016, 'Biologic Therapeutic Drug Monitoring in Australia', Journal of Gastroenterology and Hepatology (Australia), vol. 31, pp. 8 - 9, http://dx.doi.org/10.1111/jgh.13346

Elnawsra O; Fok I; Sparrow M; Gibson P; Andrews J; Connor S, 2016, 'Faecal calprotectin: Current usage and perceived beneficial effects of third-party funding on rates of colonoscopy by Australian gastroenterologists', Internal Medicine Journal, vol. 46, pp. 590 - 595, http://dx.doi.org/10.1111/imj.13056

Thompson KD; Connor SJ; Walls DM; Gollins J; Stewart SK; Bewtra M; Baumblatt GL; Holubar SD; Greenup AJ; Sechi A; Girgis A; Rubin DT; Siegel CA, 2016, 'Patients with ulcerative colitis are more concerned about complications of their disease than side effects of medications', Inflammatory Bowel Diseases, vol. 22, pp. 940 - 947, http://dx.doi.org/10.1097/MIB.0000000000000740

Andrews JM; Costello SP; Agarwal AK; Bampton P; Beswick L; Connor S; Ghaly S; O'Connor S; Pudipeddi A; Sechi A; Sparrow M; Walsh AJ, 2016, 'Conflict of interest: Real and perceived - a more mature consideration is needed', Internal Medicine Journal, vol. 46, pp. 377 - 379, http://dx.doi.org/10.1111/imj.12989

Bye W; Sparrow M; Connor SJ; Andrews JM; Watson Ng WS; Ellard K; Hume G; Antoniades SA; Walsh A, 2016, 'Su1831 Identifying “At Risk” Inflammatory Bowel Disease Patients Who May Be Targeted With a New Adjuvanted Herpes Zoster Subunit Vaccine', Gastroenterology, vol. 150, pp. S564 - S565, http://dx.doi.org/10.1016/s0016-5085(16)31930-8

Sechi A; Sawyer E; Ng WSW; Connor SJ, 2016, 'Mo1089 Proving Cost Effectiveness Through Implementation of a Nurse-Led Inflammatory Bowel Disease (IBD) Patient Advice Line and Virtual Clinic (CHEAP)', Gastroenterology, vol. 150, pp. S631 - S631, http://dx.doi.org/10.1016/s0016-5085(16)32166-7

Paramsothy S; Walsh AJ; Borody T; Samuel D; Van Den Bogaerde J; Leong RWL; Connor S; Ng W; Mitchell HM; Kaakoush NO; Kamm MA, 2015, 'Gastroenterologist perceptions of faecal microbiota transplantation', World Journal of Gastroenterology, vol. 21, pp. 10907 - 10914, http://dx.doi.org/10.3748/wjg.v21.i38.10907

Ko Y; Kariyawasam V; Karnib M; Butcher R; Samuel D; Alrubaie A; Rahme N; McDonald C; Cowlishaw J; Katelaris P; Barr G; Jones B; Connor S; Paven G; Chapman G; Park G; Gearry R; Leong RW, 2015, 'Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case-Control Study of Middle Eastern Migration to Australia', Clinical Gastroenterology and Hepatology, vol. 13, pp. 1453 - 1463.e1, http://dx.doi.org/10.1016/j.cgh.2015.02.045

Costello SP; Ghaly S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; O'Connor S; Connor SJ; Sparrow MP; Bampton P; Walsh AJ; Andrews JM, 2015, 'Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: The benefits to patients', Internal Medicine Journal, vol. 45, pp. 659 - 666, http://dx.doi.org/10.1111/imj.12732

Paramsothy S; Borody TJ; Lin E; Finlayson S; Walsh AJ; Samuel D; Van Den Bogaerde J; Leong RWL; Connor S; Ng W; Mitchell HM; Kaakoush N; Kamm MA, 2015, 'Donor recruitment for fecal microbiota transplantation', Inflammatory Bowel Diseases, vol. 21, pp. 1600 - 1606, http://dx.doi.org/10.1097/MIB.0000000000000405

Ghaly S; Costello S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; Antoniades S; Headon B; Connor S; Lawrance IC; Sparrow M; Walsh AJ; Andrews JM, 2015, 'Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response', Internal Medicine Journal, vol. 45, pp. 170 - 177, http://dx.doi.org/10.1111/imj.12621

Chen J-H; Corte CJ; Kariyawasam VC; Moran N; Gounder P; Collins GD; Connor SJ; Lee T; Walsh A; Koh CE; Chang J; Paramsothy S; Tattersall SJ; Lemberg DA; McLachlan A; Moore GT; Andrews JM; Leong RW, 2015, 'Su1102 Consensus Statements on the Management of Acute Severe Ulcerative Colitis', Gastroenterology, vol. 148, pp. S - 408, http://dx.doi.org/10.1016/s0016-5085(15)31373-1

Ooi S-YJ; Gounder M; Grafton R; Leach P; Bampton PA; Sechi A; Ng WSW; Connor SJ; Andrews JM, 2015, 'Tu1331 Are We Under-Recognizing Skewed Thiopurine Metabolism in IBD Patients? Routine Thiopurine Metabolite Measurement Yields Clinical Benefit at 12 Months: A Retrospective Observational Study', Gastroenterology, vol. 148, pp. S - 861, http://dx.doi.org/10.1016/s0016-5085(15)32919-x

Julsgaard M; Christensen LA; Gibson PR; Gearry RB; Fallingborg J; Kjeldsen J; Wildt S; Svenningsen L; Connell W; Hvas CL; Sparrow M; Walsh A; Connor SJ; Radford-Smith GL; Lawrance IC; Andrews JM; Ellard K; Rosella O; Grosen A; Santamaria JD; Bell S, 2015, '540 Adalimumab and Infliximab Levels in Neonates (ERA Study)', Gastroenterology, vol. 148, pp. S - 108, http://dx.doi.org/10.1016/s0016-5085(15)30372-3

Ooi S-YJ; Gounder M; Grafton R; Leach P; Bampton PA; Sechi A; Ng WSW; Connor SJ; Andrews JM, 2015, 'Tu1330 Thiopurine Metabolite Testing to Guide Management in Inflammatory Bowel Disease (IBD) Yields Clinical Benefit At 12 Months: A Retrospective Observational Study', Gastroenterology, vol. 148, pp. S - 861, http://dx.doi.org/10.1016/s0016-5085(15)32918-8

Heap GA; Weedon MN; Bewshea CM; Singh A; Chen M; Satchwell JB; Vivian JP; So K; Dubois PC; Andrews JM; Annese V; Bampton P; Barnardo M; Bell S; Cole A; Connor SJ; Creed T; Cummings FR; D'Amato M; Daneshmend TK; Fedorak RN; Florin TH; Gaya DR; Greig E; Halfvarson J; Hart A; Irving PM; Jones G; Karban A; Lawrance IC; Lee JC; Lees C; Lev-Tzion R; Lindsay JO; Mansfield J; Mawdsley J; Mazhar Z; Parkes M; Parnell K; Orchard TR; Radford-Smith G; Russell RK; Reffitt D; Satsangi J; Silverberg MS; Sturniolo GC; Tremelling M; Tsianos EV; Van Heel DA; Walsh A; Watermeyer G; Weersma RK; Zeissig S; Rossjohn J; Holden AL; Ahmad T, 2014, 'HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants', Nature Genetics, vol. 46, pp. 1131 - 1134, http://dx.doi.org/10.1038/ng.3093

Julsgaard M; Christensen LA; Fallingborg J; Gearry R; Radford-Smith G; Walsh A; Kjeldsen J; Sparrow MP; Andrews JM; Connor SJ; Lawrence I; Gibson PR; Rosella O; Grosen A; Bell SJ, 2014, 'Intra-uterine ExposuRe to Anti-TNF-alpha therapy (ERA study): Infliximab and adalimumab cord blood levels correlate with maternal levels at birth', JOURNAL OF CROHNS & COLITIS, vol. 8, pp. S34 - S35, http://dx.doi.org/10.1016/S1873-9946(14)60066-0

Julsgaard M; Christensen LA; Lawrence I; Gearry R; Connell W; Grosen A; Svenningsen L; Andrews JM; Bampton P; Walsh A; Moore GT; Radford-Smith G; Brown S; Hvas CL; Kjeldsen J; Connor SJ; Sparrow MP; Fallingborg J; Bell SJ, 2014, 'Pregnancy outcome and counselling of anti-TNF-alpha treated IBD women: an ongoing international multicentre study', JOURNAL OF CROHNS & COLITIS, vol. 8, pp. S222 - S223, http://dx.doi.org/10.1016/S1873-9946(14)60497-9

Sze KCP; Ng WSW; Connor SJ, 2014, 'Thiopurine metabolite monitoring and allopurinol combination therapy: current utilisation and influence on Australian gastroenterology IBD practice', JOURNAL OF CROHNS & COLITIS, vol. 8, pp. S194 - S194, http://dx.doi.org/10.1016/S1873-9946(14)60432-3

Ghaly S; Costello S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; Headon B; Prosser R; Connor S; Lawrance IC; Sparrow M; Bampton P; Walsh A; Andrews J, 2014, 'Short term dose tailoring of anti TNF-alpha therapy delivers useful clinical efficacy in Crohn's disease patients with secondary loss of response', JOURNAL OF CROHNS & COLITIS, vol. 8, pp. S209 - S209, http://dx.doi.org/10.1016/S1873-9946(14)60466-9

Hussain MI; Hall BM; Depczynski B; Connor SJ, 2014, 'Acute renal failure and metformin-associated lactic acidosis following colonoscopy', Diabetes Research and Clinical Practice, vol. 105, http://dx.doi.org/10.1016/j.diabres.2013.12.055

Siegel CA; Thompson KD; Walls D; Connor SJ; Stewart SK; Bewtra M; Rubin DT; Baumblatt GL; Holubar SD; Greenup A-J; Sechi A; Girgis A; Gollins J, 2014, 'Sa1122 Patients With Ulcerative Colitis Are More Concerned About Complications of Their Disease Than Side Effects of Medications', Gastroenterology, vol. 146, pp. S - 205, http://dx.doi.org/10.1016/s0016-5085(14)60726-5

Thompson KD; Connor SJ; Walls D; Gollins J; Stewart SK; Bewtra M; Baumblatt GL; Holubar SD; Greenup A-J; Sechi A; Girgis A; Rubin DT; Siegel CA, 2014, 'Sa1123 What Patients Want to Know When Making Decisions About Their Treatment for Ulcerative Colitis: A Mixed Methods Approach Using Affect Trace Technology', Gastroenterology, vol. 146, http://dx.doi.org/10.1016/s0016-5085(14)60727-7

Sze KC; Siriwardana A; Sechi A; Watson Ng WS; Connor SJ, 2014, 'Sa1272 Thiopurine Prescribing and Monitoring Behavior, Including Metabolites Testing and Allopurinol Co-Therapy: An Australian Perspective From 2008 to 2013', Gastroenterology, vol. 146, pp. S - 249, http://dx.doi.org/10.1016/s0016-5085(14)60876-3

Ko Y; Karnib M; Samuels D; Alrubaie A; Rahme N; McDonald C; Katelaris P; Barr G; Jones B; Paven G; Chapman G; Park G; Meredith C; Connor S; Gearry R; Leong RWL, 2014, 'Environmental Risk Factors for Inflammatory Bowel Disease: A Case-Control Study in a Middle Eastern Migrant Population', Clinical Gastroenterology and Hepatology, vol. 12, pp. 160 - 161, http://dx.doi.org/10.1016/j.cgh.2013.09.041

Walsh A; Weltman MD; Burger DM; Vivekanandarajah S; Connor S; Howlett M; Radford-Smith G; Selby W; Veillard A; Grimm M; Travis S; Lawrence IC, 2013, 'Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease', Journal of Crohn's and Colitis, vol. 7, http://dx.doi.org/10.1016/j.crohns.2013.02.019

Ubhi BK; Cheng KK; Dong J; Janowitz T; Jodrell D; Tal-Singer R; MacNee W; Lomas DA; Riley JH; Griffin JL; Connor SC, 2012, 'Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD', MOLECULAR BIOSYSTEMS, vol. 8, pp. 3125 - 3133, http://dx.doi.org/10.1039/c2mb25194a

Koo JH; You B; Liu K; Athureliya MD; Tang CWY; Redmond D; Connor S; Leong R, 2012, 'Colorectal cancer screening practice is influenced by ethnicity of medical practitioner and patient', Journal of Gastroenterology and Hepatology, vol. 27, pp. 390 - 396, http://dx.doi.org/10.1111/j.1440-1746.2011.06872.x

Fok K; Ng WW; Henderson CJ; Connor S, 2012, 'Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab', Journal of Crohn's and Colitis, vol. 2012, pp. 708 - 712, http://dx.doi.org/10.1016/j.crohns.2012.01.008

Vivekanandarajah S; Guirgis M; Bestic E; Leong RWL; Koo JH; Ng W; Connor S, 2012, 'P331 Role of infliximab as rescue therapy in hospitalised patients with severe, steroid refractory ulcerative colitis. Local experience. Liverpool and Bankstown hospitals, South Western Sydney Local Health District. Australia', Journal of Crohn's and Colitis, vol. 6, pp. S141 - S142, http://dx.doi.org/10.1016/s1873-9946(12)60351-1

Ellard K; Connor S, 2011, 'How to treat', Australian Doctor, pp. 27 - 34

Koo JH; Arasaratnam M; Liu KH; Redmond D; Connor S; Sung JJ; Leong R, 2010, 'Knowledge, perception and practices of colorectal cancer screening in an ethnically diverse population', Cancer Epidemiology, vol. 34, pp. 604 - 610, http://dx.doi.org/10.1016/j.canep.2010.05.013

Koo JH; Athureliya MD; Tang CWY; Liu K; Wickramaratne H; Redmond D; Connor SJ; Leong RWL, 2009, 'Colorectal cancer screening practice is influenced by ethnicity of patient and general practitioner', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 24, pp. A224 - A224, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Koo JH; Wong SC; Jalaludin BB; Kneebone AB; Connor SJ; Leong R, 2008, 'Clinical and pathologic outcomes of colorectal cancer in a multi-ethnic population', Clinical Gastroenterology and Hepatology, vol. 6, pp. 1016 - 1021, http://dx.doi.org/10.1016/j.cgh.2008.03.018

Koo JH; Jalaludin BB; Kneebone AB; Connor SJ; Leong R, 2008, 'Improved survival in young women with colorectal cancer', American Journal of Gastroenterology, vol. 103, pp. 1488 - 1495, http://dx.doi.org/10.1111/j.1572-0241.2007.01779.x

Chin BW; Grimm MC; Connor SJ; Leong RW, 2006, 'Managing inflammatory bowel disease', Medicine Today, vol. 7, pp. 14 - 23

Newman R; Cuan N; Hampartzoumian T; Connor SJ; Lloyd AR; Grimm M, 2005, 'Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis', Clinical and Experimental Immunology, vol. 139, pp. 411 - 420, http://dx.doi.org/10.1111/j.1365-2249.2005.02673.x

Connor SJ; Paraskevopoulos N; Newman R, 2004, 'CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease (vol 53, pg 1287, 2004)', GUT, vol. 53, pp. 1722 - 1722, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000224407200042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Connor SJ; Paraskevopoulos N; Newman R; Cuan N; Hampartzoumian T; Lloyd AR; Grimm M, 2004, 'CCR2 expressing CD4+T lymphocytes are preferentially recruited to the ileum in Crohn's disease', Gut, vol. 53, pp. 1287 - 1294, http://dx.doi.org/10.1136/gut.2003.028225

Grimm MC; Newman R; Hassim Z; Cuan N; Connor SJ; Le Y; Wang JM; Oppenheim JJ; Lloyd AR, 2003, 'Cutting Edge: Vasoactive Intestinal Peptide Acts as a Potent Suppressor of Inflammation In Vivo by Trans-Deactivating Chemokine Receptors', Journal of Immunology, vol. 171, pp. 4990 - 4994, http://dx.doi.org/10.4049/jimmunol.171.10.4990

Connor SJ; Grimm MC, 2001, 'Heparin as an anti-inflammatory agent: It's no GAG to forget about chemokines [3]', Gut, vol. 48, pp. 738, http://dx.doi.org/10.1136/gut.48.5.738

Connor SJ; Cardillo R; Cuan N; Amansec S; Conway P; Lloyd AR; Grimm MC, 2001, 'Amelioration of TNBS colitis in mice using preblotics', Gastroenterology, vol. 120, pp. A82 - A82, http://dx.doi.org/10.1016/s0016-5085(08)80404-0

Amansec SG; Connor SJ; Cardillo R; Cuan N; Grimm MC; Conway P, 2001, 'AMELIORATION OF MURINE TNBS COLITIS USING PREBIOTICS', Journal of Gastroenterology and Hepatology, vol. 16, pp. 6 - 6, http://dx.doi.org/10.1111/j.1440-1746.2001.ca01-6.x

Connor SJ; Seow F; Ngu MC; Katelaris PH, 1999, 'The effect of dosing with omeprazole on the accuracy of the ¹³C-urea breath test in Helicobacter pylori-infected subjects', Alimentary Pharmacology and Therapeutics, vol. 13, pp. 1287 - 1293, http://dx.doi.org/10.1046/j.1365-2036.1999.00601.x

Connor SJ; Ngu MC; Katelaris PH, 1999, 'The impact of short-term ranitidine use on the precision of the ¹³C-urea breath test in subjects infected with Helicobacter pylori', European Journal of Gastroenterology and Hepatology, vol. 11, pp. 1135 - 1138, http://dx.doi.org/10.1097/00042737-199910000-00010

Norrie MWA; Chapman G; Connor SJ, 1997, 'A case of upper gastrointestinal bleeding secondary to a bread bag clip', Australian and New Zealand Journal of Medicine, vol. 27, pp. 75, http://dx.doi.org/10.1111/j.1445-5994.1997.tb00918.x

Khin-Maung-U ; Tin-Aye ; Ku-Tin-Myint ; Tin-Oo ; Myo-Khin ; Thackway SA; Connor SJ; Bolin TD; Duncombe VM, 1992, 'In vitro hydrogen production by enteric bacteria cultured from children with small bowel bacterial overgrowth', Journal of Pediatric Gastroenterology and Nutrition, vol. 14, pp. 192 - 197, http://dx.doi.org/10.1097/00005176-199202000-00013

Kim AH; Girgis A; De Cruz P; Siegel CA; Karimi N; Ruban SO; Sechi AJ; Ng WSW; Andrews JM; Connor SJ, 'Development and Feasibility of a Web-Based Decision Aid for Patients With Ulcerative Colitis: Qualitative Pilot Study (Preprint)', , http://dx.doi.org/10.2196/preprints.15946

Lord A; Mortlock S; Montgomery G; Simms LA; Krishnaprasad K; Hanigan K; Doecke JD; Gearry R; Lawrance I; Bampton PA; Andrews JM; Mahy G; Connor SJ; Sparrow M; Bell S; Walsh A; Radford-Smith GL, 2018, 'Genetically distinct signatures of mild and severe ulcerative colitis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 103 - 104, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Little RD; Chu IE; van der Zanden EP; Flanagan E; Bell SJ; Sparrow MP; Shelton E; Connor SJ; Roblin X; Ward MG, 2018, 'Is there a difference in adalimumab drug levels according to pen versus syringe use: An international, multicenter retrospective analysis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 102 - 102, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Paramsothy S; Kamm MA; Nielsen S; Deshpande N; Faith J; Clemente JC; Paramsothy R; Walsh A; van den Bogaerde J; Samuel D; Leong RW; Connor SJ; Ng WSW; Lin E; Wilkins M; Colombel JF; Borody TJ; Mitchell HM; Kaakoush NO, 2018, 'IN FECAL MICROBIOTA TRANSPLANTATION (FMT) FOR ULCERATIVE COLITIS, FUSOBACTERIUM IS ASSOCIATED WITH LACK OF REMISSION, WHILE METABOLIC SHIFTS TO STARCH DEGRADATION AND SHORT CHAIN FATTY ACID PRODUCTION ARE ASSOCIATED WITH REMISSION - RESULTS FROM THE RANDOMIZED CONTROLLED FOCUS STUDY', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, Washington, DC, pp. S35 - S35, presented at Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week, Washington, DC, 02 June 2018 - 05 June 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450011100099&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lord A; Mortlock S; Montgomery G; Simms L; Krishnaprasad K; Hanigan K; Doecke JD; Gearry R; Lawrance I; Bampton PA; Andrews JM; Mahy G; Connor SJ; Sparrow M; Bell S; Walsh A; Radford-Smith GL, 2018, 'GENETICALLY DISTINCT SIGNATURES OF MILD AND SEVERE ULCERATIVE COLITIS', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, Washington, DC, pp. S1025 - S1025, presented at Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week, Washington, DC, 02 June 2018 - 05 June 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450011104106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pulusu SSR; Srinivasan A; Krishnaprasad K; Cheng D; Mogilevski T; Flanagan E; Keung C; Wu Y; Prosser R; Sawyer EA; Rizvi Q-U-A; Su HY; Leung WK; Edmundson A; Cooke S; Mahy G; Thin L; Radford-Smith GL; Sparrow M; Andrews JM; Connor SJ; Bampton PA; Simon G; van Langenberg DR; Bell S; De Cruz P; Begun J; Ng SC; Travis SP; Lawrance I, 2018, 'VEDOLIZUMAB(VDZ) REAL WORLD OUTCOMES IN ULCERATIVE COLITIS (UC)', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, Washington, DC, pp. S836 - S836, presented at Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week, Washington, DC, 02 June 2018 - 05 June 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450011103257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Krishnaprasad K; Walsh A; Begun J; Bell S; Carter D; Grafton R; Sechi A; Sewell K; McMahon A; Connor SJ; Radford-Smith GL; Andrews JM, 2018, 'CROHN'S COLITIS CARE (CCCARE) - DEVELOPMENT AND TESTING OF A BESPOKE CLOUD-BASED CLINICAL MANAGEMENT SYSTEM FOR INFLAMMATORY BOWEL DISEASE (IBD)', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, Washington, DC, pp. S892 - S892, presented at Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week, Washington, DC, 02 June 2018 - 05 June 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450011103425&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wu Y; Lin B; Thilakanathan C; Lehmann P; Xuan W; Mohsen W; Toong C; Ng W; Connor S, 2017, 'Secondary loss of response is the most common indication for infliximab level testing in inflammatory bowel disease: The Australian experience', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 153 - 154, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100273&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Seang S; Kanazaki R; Krishnaprasad K; Hanigan K; Bampton P; Prosser R; Andrews J; Grafton R; Mahy G; Bell S; Xuan W; Ng W; Sparrow M; Walsh A; Radford-Smith G; Connor S, 2017, 'Clinical predictors of severe ulcerative colitis requiring colectomy in Australia', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 145 - 145, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wen A; Selvanderan SP; Wu Y; Xuan W; Andrews JM; Koo JH; Ng W; Connor S, 2017, 'Assessment of anti-tumor necrosis factor drug levels in people with Crohn's disease changes management decisions more often when done for loss of response than during remission', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 152 - 152, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100271&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nguyen MTA; Antoniades S; Xuan W; Ghaly S; Connor S; Ng W, 2017, 'Treatment of ulcerative colitis with infliximab: Real-world outcomes are better than pivotal trials and improved with dose intensification', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 139 - 139, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100249&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lin B; Wu Y; Thilakanathan C; Lehmann P; Xuan W; Mohsen W; Toong C; Ng W; Connor S, 2017, 'Biological level testing in inflammatory bowel disease identifies inappropriate use of infliximab, with substantial associated cost savings', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 132 - 133, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100240&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mitrev N; Vande Casteele N; Seow C; Andrews JM; Connor SJ; Moore G; Barclay M; Begun J; Bryant R; Chan W; Corte C; Ghaly S; Lemberg DA; Kariyawasam V; Lewindon P; Martin J; Mountifield R; Radford-Smith G; Slobodian P; Sparrow M; Toong C; Van Langenberg D; Ward MG; Leong RW, 2017, 'Therapeutic drug monitoring-guided biological drug therapy in inflammatory bowel disease: Consensus statements of the Australian Inflammatory Bowel Disease Association (AIBDA) and Gastroenterological Society of Australia (GESA)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 136 - 138, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100247&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Verdon C; Sawyer E; Connor S; Ng W; Turner I, 2017, 'Drug-induced systemic lupus erythematosus in patients with inflammatory bowel disease treated with anti-tumor necrosis factor inhibitors: A case series', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 150 - 150, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100268&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pulusu SSR; Krishnaprasad K; Cheng D; Mogilevski T; Flanagan E; Parthasarathy N; Wu C; Prosser R; Sawyer E; Rizvi Q-U-A; Taylor K; Sewell K; Cooke S; Mahy G; Radford-Smith G; Sparrow M; Andrews J; Connor S; Bampton P; Ghaly S; Van Langenberg D; Bell S; De Cruz P; Begun J; Lawrance I, 2017, 'Vedolizumab: Real-life outcomes to therapy in ulcerative colitis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 142 - 142, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100255&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pulusu SSR; Krishnaprasad K; Cheng D; Mogilevski T; Flanagan E; Parthasarathy N; Wu C; Prosser R; Sawyer E; Rizvi QUA; Taylor K; Cooke S; Mahy G; Sparrow M; Andrews J; Connor S; Bampton P; Ghaly S; Van Langenberg D; Bell S; De Cruz P; Begun J; Lawrance I, 2017, 'Vedolizumab: Real-life outcomes to therapy in Crohn's disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 143 - 143, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100256&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Krishnaprasad K; Walsh A; Begun J; Bell S; Carter D; Grafton R; Sechi A; Sewell K; Mcmahon A; Connor S; Radford-Smith G; Andrews JM, 2017, 'Crohn's Colitis Care (CCCare): A bespoke cloud-based clinical management system for inflammatory bowel disease - development and beta testing', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 131 - 131, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100237&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lawrance IC; Baird A; Lightowler D; Radford-Smith G; Andrews JM; Connor S, 2017, 'A multi-centre double blind randomised placebo-controlled study of the use of rectal tacrolimus in the treatment of resistant ulcerative proctitis', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. S4 - S5, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398606900008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sechi A; Sawyer E; Ng W; Connor S, 2016, 'Proving cost effectiveness through implementation of a nurse-led inflammatory bowel disease patient advice line and virtual clinic (CHEAP)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 174 - 174, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700314&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Paramsothy S; Kaakoush NO; Kamm M; Faith J; Clemente JC; Walsh A; van den Bogaerde J; Samuel D; Leong R; Connor S; Ng W; Paramsothy R; Lin E; Colombel J; Borody T; Mitchell HM, 2016, 'Effect on the intestinal microbiota and clinical outcome of faecal microbiota transplantation in patients with UC', in HELICOBACTER, WILEY-BLACKWELL, Magdeburg, GERMANY, pp. 72 - 72, presented at 29th International Workshop on Helicobacter and Microbiota in Inflammation and Cancer, Magdeburg, GERMANY, 15 September 2016 - 17 September 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383517600017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Paramsothy S; Kamm MA; Walsh A; van den Bogaerde J; Samuel D; Leong RW; Connor SJ; Ng WSW; Paramsothy R; Kaakoush N; Mitchell HM; Xuan W; Lin E; Borody T, 2016, 'Multi Donor Intense Faecal Microbiota Transplantation is an Effective Treatment for Resistant Ulcerative Colitis: A Randomised Placebo-Controlled Trial', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, San Diego, CA, pp. S122 - S123, presented at Digestive Disease Week (DDW), San Diego, CA, 20 May 2016 - 24 May 2016, http://dx.doi.org/10.1016/S0016-5085(16)30517-0

Sechi A; Sawyer E; Ng W; Connor S, 2016, 'Proving cost effectiveness through implementation of a nurse-led inflammatory bowel disease patient advice line and virtual clinic (CHEAP)', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. S494 - S494, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374496600879&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ko Y; Paramsothy S; Sarathy K; Shan P; Ng W; Connor S, 2015, 'Bone health in inflammatory bowel disease patients - management by australian gastroenterologists is variable and poorly consistent with current guidelines', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 131 - 131, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364505900255&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hsu J; Greenup A; Kordian T; Sze K; Bassan M; Koo K; Ng W; Connor S, 2015, 'A single-blinded, randomised clinical trial: comparison between 2 different bowel preparation formulations split PrepKitC, a combined polyethylene glycol and sodium picosulfate-based solution and split prep Moviprep, a polyethylene glycol-based solution in the setting of outpatient colonoscopy', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 45 - 45, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364505900088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chen J-H; Corte CJ; Kariyawasam VC; Moran N; Gounder P; Collins GD; Connor SJ; Lee T; Walsh A; Koh CE; Chang J; Paramsothy S; Tattersall SJ; Lemberg DA; McLachlan A; Moore GT; Andrews JM; Leong RW, 2015, 'Consensus Statements on the Management of Acute Severe Ulcerative Colitis', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, Washington, DC, pp. S408 - S408, presented at 46th Annual Digestive Disease Week (DDW), Washington, DC, 16 May 2015 - 19 May 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360117100027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Julsgaard M; Christensen LA; Gibson PR; Gearry RB; Fallingborg J; Kjeldsen J; Wildt S; Svenningsen L; Connell W; Hvas CL; Sparrow M; Walsh A; Connor SJ; Radford-Smith GL; Lawrance IC; Andrews JM; Ellard K; Rosella O; Grosen A; Santamaria JD; Bell S, 2015, 'Adalimumab and Infliximab Levels in Neonates (ERA Study)', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, Washington, DC, pp. S108 - S108, presented at 46th Annual Digestive Disease Week (DDW), Washington, DC, 16 May 2015 - 19 May 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000359414700373&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ooi S-YJ; Gounder M; Grafton R; Leach P; Sechi A; Ng W; Connor S; Bampton P; Andrews JM, 2015, 'Thiopurine metabolite testing to guide management in inflammatory bowel disease (IBD) yields clinical benefit at 12 months: A retrospective observational study.', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. S290 - S290, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000353811200536&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ooi S-YJ; Gounder M; Grafton R; Leach P; Sechi A; Ng W; Connor S; Bampton P; Andrews JM, 2015, 'Are we under-recognizing skewed thiopurine metabolism in IBD patients? Routine thiopurine metabolite measurement yields clinical benefit at 12 months: A retrospective observational study.', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. S255 - S255, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000353811200469&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ooi SY; Gounder M; Grafton R; Leach P; Bampton P; Ng W; Connor S; Andrews JM, 2014, 'Thiopurine metabolite monitoring in inflammatory bowel disease (IBD): A retrospective observational study evaluating the longer-term outcomes (>= 12 months) of metabolite level led clinical management preliminary findings', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 122 - 122, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000240&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Heap GA; Singh A; Bewshea CM; Weedon M; Dubois P; Andrews JM; Annese V; Bampton PA; Bell S; Cole A; Connor SJ; Creed T; D'Amato M; Fedorak RN; Florin TH; Gaya DR; Greig E; Halfvarson J; Irving PM; Karban A; Lawrance IC; Lev-Tzion R; Lindsay JO; Mawsley J; Mazher Z; Orchard TR; Radford-Smith GL; Reffitt D; Silverberg MS; Sturniolo GC; Tsianos EV; Walsh A; Zeissig S; Holden AL; Ahmad T, 2014, 'Thiopurine Induced Pancreatitis in Inflammatory Bowel Disease: Clinical Features and Genetic Determinants', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, Chicago, IL, pp. S2 - S2, presented at 55th Annual Meeting of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / Digestive Disease Week (DDW), Chicago, IL, 03 May 2014 - 06 May 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000371236400007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Paramsothy S; Sarathy K; Ng W; Connor S, 2014, 'Bone health management in inflammatory bowel disease patients amongst Australian gastroenterologists', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. S177 - S177, http://dx.doi.org/10.1016/S1873-9946(14)60394-9

Costello S; Ghaly S; O'Connor S; Agarwal A; Beswick L; Headon B; Pudipeddi A; Sechi A; Prosser R; Connor S; Sparrow M; Bampton P; Walsh A; Andrews J, 2014, 'Compassionate access use of anti-TNF therapy in ulcerative colitis in six Australian IBD centres has been beneficial to patient outcomes', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. S288 - S288, http://dx.doi.org/10.1016/S1873-9946(14)60649-8

Greenup A-J; Koo J; Sechi A; Levy M; Ng W; Connor S, 2013, 'Prospective single-blinded single-centre randomized controlled trial comparing moviprep with prepkit c using standard split preparation protocol in patients for elective colonoscopy', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 19 - 20, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sze KCP; Sechi A; Ng W; Connor S, 2013, 'Thiopurine use and metabolites monitoring in inflammatory bowel disease: Current practice in Australia', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 97 - 97, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Costello S; Ghaly S; Beswick L; Pudipeddi A; Agarwal A; Headon B; Seschi A; Connor S; Sparrow M; Walsh A; Andrews JM, 2013, 'Compassionate access use of Anti-TNF therapy in Ulcerative Colitis in four Australian IBD centres has been beneficial to patient outcomes', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 105 - 105, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Paramsothy S; Sarathy K; Ng W; Connor S, 2013, 'Bone health in inflammatory bowel disease patients - a survey of australian gastroenterologists', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 107 - 107, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900227&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Julsgaard M; Christensen LA; Gearry R; Andrews J; Rosella O; Connor S; Walsh A; Brown S; Connell W; Gibson P; Bell SJ, 2013, 'Intra-uterine exposure to anti-TNF-alpha therapy (ERA study): Neonatal levels of anti TNF antibodies correlate with duration of therapy in pregnancy', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 85 - 85, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ghaly S; Costello S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; Headon B; Connor S; Sparrow M; Walsh AJ; Andrews JM, 2013, 'Compassionate access use of anti-TNF therapy in Crohn's disease reduces the need for steroids in an Australian multicenter retrospective review', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 105 - 106, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900223&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Connor SJ; Lim YY; Tate C; Entwistle H; Morris J; Whiteside S; Sergeant J; Wilson M; Beetles U; Boggis C; Gilbert F; Astley S, 2012, 'A comparison of reading times in full-field digital mammography and digital breast tomosynthesis', in BREAST CANCER RESEARCH, BIOMED CENTRAL LTD, Leeds, ENGLAND, presented at Annual Scientific Meeting of the British-Society-of-Breast-Radiology, Leeds, ENGLAND, 12 November 2012 - 13 November 2012, http://dx.doi.org/10.1186/bcr3281

De Cruz P; Kamm MA; Hamilton AL; Ritchie KJ; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Sparrow M; Jakobovits S; Florin TH; Gibson PR; Debinski H; Gearry RB; Macrae FA; Leong RW; Kronborg I; Connor SJ; Radford-Smith G; Selby W; Johnston MJ; Woods R; Keck J; Brouwer R; Connell W; Brown SJ; Bell S; Lust M; Elliott R; Desmond P, 2012, 'Adalimumab Prevents Post-Operative Crohn's Disease Recurrence, and is Superior to Thiopurines: Early Results From the POCER Study', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, San Diego, CA, pp. S212 - S212, presented at Digestive Disease Week (DDW), San Diego, CA, 19 May 2012 - 22 May 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306994301140&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

De Cruz P; Kamm MA; Hamilton AL; Ritchie KJ; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Sparrow M; Jakobovits S; Florin TH; Gibson PR; Debinski H; Gearry RB; Macrae FA; Leong RW; Kronborg I; Connor SJ; Radford-Smith G; Selby W; Johnston MJ; Woods R; Keck J; Brouwer R; Connell W; Brown SJ; Bell S; Lust M; Elliott R; Desmond P, 2012, 'Clinical Risk Stratification Predicts Development of Endoscopic Recurrence After Crohn's Disease Surgery: Early Results From the POCER Study', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, San Diego, CA, pp. S568 - S568, presented at Digestive Disease Week (DDW), San Diego, CA, 19 May 2012 - 22 May 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306994303165&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Aggarwal V; Day AS; Connor S; Leach ST; Grimm M; Craig PI, 2010, 'Correlation between capsule endoscopy findings and Crohn's disease activity index, faecal calprotectin and S100A12 in small bowel Crohn's disease patients in clinical remission', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A100 - A100, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200272&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Koo JH; You B; Athureliya MD; Tang CWY; Liu K; Redmond DM; Connor SJ; Leong RWL, 2010, 'Colorectal cancer screening practice is influenced by ethnicity of patient and medical practitioner', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A141 - A141, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000282181400463&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Guirgis M; Manoharan S; Kwok R; Scott DR; Lee AU; Connor SJ; Levy M, 2009, 'TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN CHRONIC HEPATITIS B INFECTION: REDUCE NUMBER OF BIOPSIES & SAVE MONEY', in HEPATOLOGY, JOHN WILEY & SONS INC, Boston, MA, pp. 543A - 543A, presented at 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston, MA, 30 October 2009 - 03 November 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270456000499&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Aggarwal V; Connor S; Scott D; Grimm M; Craig PI, 2009, 'Capsule endoscopy findings in small bowel Crohn's disease subjects in clinical remission: correlation with the Crohn's disease activity index', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A312 - A312, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200248&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Koo JH; Arasaratnam M; Liu KH; Redmond D; Connor SJ; Leong R, 2008, 'Improving participation in colorectal cancer screening in a multi-ethnic population', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A205 - A205, presented at Journal of Gastroenterology and Hepatology, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259960100062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Holden S; Connor SJ; Quinn JE; Levy MT, 2008, 'Is there still a role for lamivudine? Baseline HBeAg status and viral load at 6 and 12 months predicts long-term effectiveness of lamivudine in CHB patients', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A186 - A186, presented at Journal of Gastroenterology and Hepatology, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259960100024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Koo JH; Jalaludin B; Wong CS; Poxon V; Kneebone A; Connor SJ; Leong RW, 2007, 'Colorectal cancer in females is associated with poorer outcomes', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, Washington, DC, pp. A621 - A621, presented at Digestive Disease Week Meeting/108th Annual Meeting of the American-Gastroenterological-Association, Washington, DC, 19 May 2007 - 24 May 2007, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000245927605166&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Koo JH; Kneebone A; Jalaludin B; Poxon V; Wong CS; Connor SJ; Leong RW, 2007, 'The impact of ethnicity and culture on clinical outcomes of colorectal cancer in Sydney South West', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, Washington, DC, pp. A621 - A621, presented at Digestive Disease Week Meeting/108th Annual Meeting of the American-Gastroenterological-Association, Washington, DC, 19 May 2007 - 24 May 2007, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000245927605167&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Katelaris PH; Connor SJ; Seow F; Huntley S; Ngu MC, 1998, 'The effect of short term omeprazole use on the accuracy of the C-13-urea breath test in Helicobacter pylori infected subjects', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. A53 - A53, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000076309500191&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Julsgaard M; Christensen LA; Gibson PR; Fallingborg J; Gearry R; Walsh A; Kjeldsen J; Connell W; Sparrow MP; Radford-Smith G; Andrews JM; Connor SJ; Lawrence I; Wildt S; Moore GT; Svenningsen L; Rosella O; Grosen A; Bell SJ, 2014, 'Adalimumab and Infliximab levels in neonates correlate with duration of treatment in pregnancy (ERA study)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, Vol. 29, pp. 117 - 118, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000231&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Elnawsra O; Fok I; Connor S; Sparrow M; Gibson P; Andrews J, 2014, 'Third party funding for Fecal Calprotectin is likely to reduce colonoscopy usage in Australia: Gastroenterologists' use and knowledge of its role in clinical practice', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, Vol. 29, pp. 107 - 108, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000213&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Barnes A; Krishnaprasad K; Carter D; Walsh A; Grafton R; Hughes J; Kaazan P; Cabaero A; Williams A; Ng W; Wierzbicki A; Connor S; Andrews J, 2021, 'Novel inflammatory bowel disease-specific electronic medical record allows scalable auditing of disease severity, therapy, complications, and the unmet need in care', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 36, pp. 106 - 107, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800170&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Abeyratne K; Harb M; Bensted K; Ghaly S; Connor S; Andrews J; Lynch K, 2021, 'Validity of stomal calprotectin measurement in assessing Crohn's disease activity', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 36, pp. 125 - 125, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800198&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pipicella JL; Vernon-Roberts A; Walsh A; Wierzbicki A; Day A; Carter DW; Giles E; Gearry R; Connor SJ; Andrews JM; Dutt S, 2021, 'USING A CONSENSUS-BASED METHOD TO DEVELOP A NOVEL PAEDIATRIC-SPECIFIC INFLAMMATORY BOWEL DISEASE EHEALTH CLINICAL MANAGEMENT SYSTEM', in GUT, BMJ PUBLISHING GROUP, Vol. 70, pp. A108 - A109, presented at Abstracts of the International Digestive Disease Forum (IDDF), Hong Kong, 4–5 September 2021, http://dx.doi.org/10.1136/gutjnl-2021-IDDF.127

Zhang L; Mohsen W; Wark G; Williams A-J; Sechi A; Koo JH; Xuan W; Ng W; Connor S; Bassan M, 2020, 'Is quality of bowel preparation affected by ambient temperature?', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 222 - 222, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200333&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

De Gregorio M; Lee T; Krishnaprasad K; Amos G; An Y-K; Bastian-Jordan M; Begun J; Borok N; Brown DJM; Cheung W; Connor S; Gerstenmaier J; Gilbert LE; Gilmore R; Gu B; Kutaiba N; Lee A; Mahy G; Srinivasan A; Thin L; Welman CJ; Yong EXZ; De Cruz P; Van Langenberg D; Sparrow M; Ding NS, 2020, 'Higher anti-tumor necrosis factor-alpha drug levels are associated with improved radiological outcomes in patients with perianal fistulizing Crohn's disease: A retrospective multicenter study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 133 - 133, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200192&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Willmann L; Wang G; Karimi N; Connor S; Descallar J; Kanazaki R; Ng W; O'Connor K; Pipicella JL; Huang V; Williams A-J, 2020, 'Using a novel patient decision aid to improve the quality of pregnancy-related shared decision making in inflammatory bowel disease: A pilot study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 143 - 143, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200207&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jacob R; Chu V; Ng W; Williams A-J; Connor S, 2020, 'Clostridium difficile infection in patients with inflammatory bowel disease: An Australian experience', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 146 - 146, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200212&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gu B; Venkatesh K; Williams AJ; Ng W; Corte C; Ghaly S; Xuan W; Paramsothy S; Connor S, 2020, 'Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 14, pp. S490 - S491, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000518803402169&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Haifer C; Kelly CR; Paramsothy S; Andresen D; Papanicolas LE; Mckew GL; Borody TJ; Kamm MA; Costello SP; Andrews JM; Begun J; Chan HT; Connor SJ; Ghaly DS; Johnson P; Lemberg D; Paramsothy R; Andrew R; Sheorey H; Van Der Poorten D; Leong RW, 2020, 'Sa1913 CONSENSUS GUIDELINES FOR THE REGULATION, PRODUCTION AND USE OF FECAL MICROBIOTA TRANSPLANTATION IN CLINICAL PRACTICE', in Gastroenterology, Elsevier BV, Vol. 158, http://dx.doi.org/10.1016/s0016-5085(20)31872-2

Kanazaki R; Girgis A; Descallar J; Smith B; Connor S, 2019, 'National survey of Australian gastroenterologists' knowledge and attitudes regarding inflammatory bowel disease guidelines show high confidence but low adherence', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 143 - 143, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100225&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ow T; Schoeman M; Hebbard G; Connor S; Begun J; Mortimore M; Mountifield R; Van der Poorten D; Moore G; Grimm M; Lim P; Strasser S; Andrews J, 2019, 'Colonoscopy recalls: Whose issue is it and what are the resource implications of committing to a hospital-based recall service?', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 213 - 214, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100336&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Williams A; Sechi A; Cabaero A; Kuzet G; Dunning A; Ng W; Connor S, 2019, 'Crohn's Colitis Care (CCCare): Patient perception before implementation of a bespoke cloud-based clinical management system for inflammatory bowel disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 125 - 125, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100200&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

An Y; Prince D; Gardiner F; Linedale E; Andrews J; Connor S; Begun J, 2019, 'Effectiveness of fecal calprotectin testing to identify patients with organic gastrointestinal diseases: A systematic review and diagnostic meta-analysis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 174 - 174, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100269&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wu N; Chan P; Crane H; Nguyen P; Williams A; Ng W; Connor S, 2019, 'Rapid and accelerated infliximab infusions for standard-dose and dose-intensified patients with inflammatory bowel disease: Safety and patient satisfaction', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 149 - 150, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100234&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lim E; Thai M; Hendy P; Alchlaihawi M; Leong R; Connor S; Ng W; Gu B; van Langenberg D; Thin L; Schulberg J; Kamm M; Gilmore R; Taylor K; Sallis O; Andrews J; Daker C; Barclay M; Wark G; Ghaly S; Begun M; Krishnaprasad K; Begun J, 2019, 'Endoscopic balloon dilatation is safe and has a high success rate in patients with stricturing Crohn's disease', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 13, pp. S374 - S374, http://dx.doi.org/10.1093/ecco-jcc/jjy222.647

Krishnaprasad K; Walsh A; Begun J; Bell S; Carter D; Grafton R; Sechi A; Sewell K; McMahon A; Connor S; Radford-Smith G; Andrews J, 2018, 'Crohn's colitis care (CCCare): development and testing of a bespoke cloud-based clinical management system for inflammatory bowel disease (IBD)', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 12, pp. S266 - S268, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000427318901105&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Little R; Chu I; van der Zanden E; Flanagan E; Bell S; Sparrow M; Shelton E; Connor S; Roblin X; Ward M, 2018, 'Is there a difference in adalimumab drug levels according to pen vs. syringe use: An international, multi-centre retrospective analysis', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 12, pp. S469 - S470, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000427318902092&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pulusu SSR; Srinivasan A; Krishnaprasad K; Cheng D; Mogilevski T; Flanagan E; Keung C; Wu C; Prosser R; Sawyer E; Rizvi Q-U-A; Su H; Leung W-K; Edmundson A; Cooke S; Mahy G; Thin L; Radford-Smith G; Sparrow M; Andrews JM; Connor S; Bampton P; Ghaly S; Van Langenberg D; Bell S; De Cruz P; Begun J; Ng S; Travis S; Lawrance I, 2018, 'Vedolizumab (VDZ) real-world outcomes in ulcerative colitis (UC)', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 12, pp. S395 - S396, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000427318901348&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Paramsothy S; Kamm M; Nielsen S; Deshpande N; Faith J; Clemente J; Paramsothy R; Walsh A; van den Bogaerde J; Samuel D; Leong R; Connor S; Ng W; Lin E; Wilkins M; Colombel J-F; Borody T; Mitchell H; Kaakoush N, 2018, 'In faecal microbiota transplantation (FMT) for ulcerative colitis, fusobacterium is associated with lack of remission, while metabolic shifts to starch degradation and short-chain fatty acid production are associated with remission (FOCUS study)', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 12, pp. S13 - S14, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000427318900020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kim AH; Sechi AJ; Ruban SO; Ng W; Girgis A; Andrews JM; Siegel CA; Connor SJ, 2017, 'Feasibility and acceptability of an Internet-based decision aid (myAID) for patients with ulcerative colitis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 32, pp. 130 - 130, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100236&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mohsen W; Wark G; Greenup A; Sechi A; Sawyer E; Koo JH; Ng W; Connor S, 2017, 'Prospective, single-blinded, single-center randomized controlled trial comparing outcomes of bowel preparation for colonoscopy using MoviPrep or Prepkit-C in patients with or without inflammatory bowel disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 32, pp. 25 - 25, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Paramsothy S; Kaakoush NO; Kamm MA; Faith JJ; Clemente JC; Walsh AJ; Van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Paramsothy R; Lin E; Colombel JF; Borody TJ; Mitchell HM, 2016, 'Faecal microbiota transplantation (FMT) in ulcerative colitis is associated with specific bacterial changes: stool and colonic mucosa 16S microbiota analysis from the randomised controlled FOCUS study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, Vol. 31, pp. 125 - 126, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700223&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Paramsothy S; Kamm MA; Walsh AJ; Van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Paramsothy R; Kaakoush N; Mitchell HM; Xuan W; Lin E; Borody TJ, 2016, 'Multi donor intense faecal microbiota transplantation is an effective treatment for resistant ulcerative colitis: a randomised placebocontrolled trial and microbiota analysis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, Vol. 31, pp. 143 - 143, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700253&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Paramsothy S; Kamm M; Walsh A; van den Bogaerde J; Samuel D; Leong R; Connor S; Ng W; Paramsothy R; Kaakoush N; Mitchell H; Xuan W; Lin E; Borody T, 2016, 'Multi-donor intense faecal microbiota transplantation is an effective treatment for resistant ulcerative colitis: a randomised placebo-controlled trial', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 10, pp. S14 - S14, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374496600018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bye W; Sparrow M; Connor SJ; Andrews JM; Ellard K; Ng W; Hume G; Antoniades S; Walsh AJ, 2016, 'Identifying 'at-risk' inflammatory bowel disease patients who may be targeted with a new adjuvant herpes zoster subunit vaccine', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 10, pp. S365 - S366, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374496600644&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chen J-H; Corte C; Kariyawasam V; Moran N; Gounder P; Collins G; Connor S; Lee TW; Walsh A; Koh CE; Chang J; Paramsothy S; Tattersall S; Lemberg DA; McLachlan A; Moore G; Andrews J; Leong R, 2015, 'Consensus Statements on the Management of Acute Severe Ulcerative Colitis', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 9, pp. S253 - S253, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000353811200465&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Julsgaard M; Christensen LA; Gibson PR; Gearry R; Fallingborg J; Kjeldsen J; Wildt S; Svenningsen L; Connell W; Hvas CL; Sparrow MP; Walsh A; Connor SJ; Radford-Smith G; Lawrence I; Andrews JM; Ellard K; Rosella O; Grosen A; Santamaria J; Bell SJ, 2015, 'Adalimumab and infliximab levels in neonates (ERA study)', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 9, pp. S2 - S3, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000353811200005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Aggarwal V; Day A; Leach S; Connor SJ; Brown GJ; Singh R; Freidman A; Grimm M; Craig P, 2012, 'Multicenter capsule endoscopy study of patients with small bowel Crohn's disease in clinical remission: long-term follow-up and correlation with faecal biomarkers and clinical outcome', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, Vol. 27, pp. 96 - 97, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308642600201&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Davison SA; Nguyen R; Connor S; Ng W; Dobbins TA; Maley M; Monaharan S; Levy MT, 2010, 'Vitamin D deficiency is common in patients with genotype 1 chronic hepatitis C and is associated with lower rate of SVR', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, Vol. 25, pp. A132 - A132, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Siriwardana AS; Koo JH; Ng WSW; Connor SJ, 2009, 'Azathioprine, 6-mercaptopurine and thiopurine s-methyltransferase levels in inflammatory bowel disease: what is current clinical practice?', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, Vol. 24, pp. A311 - A312, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200246&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Siriwardana AS; Koo JH; Ng WSW; Connor SJ, 2009, 'Azathioprine, 6-mercaptopurine and thiopurine s-methyltransferase levels in gastroenterology and rheumatology: a comparison of clinical practice in Australia', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, Vol. 24, pp. A222 - A223, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thomson AD; Ng WSW; Connor SJ, 2009, 'Response to infliximab in patients with steroid refractory and steroid dependent ulcerative colitis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, Vol. 24, pp. A317 - A318, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200263&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Guirgis M; Manoharan S; Scott DR; Kwok R; Lee AU; Connor SJ; Levy MT, 2009, 'Transient elastography (Fibroscan) in chronic hepatitis B infection: reduce number of biopsies & save money', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, Vol. 24, pp. A308 - A308, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200238&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wiseman E; Gilbert D; Schlaphoff G; Chow C; Levy M; Connor S, 2006, 'Adequacy of liver biopsies: size does matter', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, BLACKWELL PUBLISHING, Vol. 21, pp. A248 - A248, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000247320600003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Koo JH; Kneebone AB; Connor SJ; Jalaludin BB; Poxon V; Wong SK; Leong R, 2006, 'The impact of ethnicity and culture on clinical outcomes of colorectal cancer in South Western Sydney', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Vol. 21, pp. A281 - A281, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000247320600069&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Koo JH; Jalaludin BB; Wong SK; Poxon V; Kneebone AB; Connor SJ; Leong R, 2006, 'Colorectal cancer in females is associated with poorer outcomes', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Vol. 21, pp. A266 - A266, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000247320600039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Connor SJ; Cardillo R; Cuan N; Amansec S; Conway P; Lloyd AR; Grimm MC, 2001, 'Amelioration of TNBS colitis in mice using prebiotics', in GASTROENTEROLOGY, W B SAUNDERS CO, Vol. 120, pp. A82 - A82, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000168514700403&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Connor SJ; Hassim Z; Cardillo R; Lloyd AR; Grimm MC, 2000, 'Chemokine receptor expression and function in lamina propria mononuclear cells of the human colon.', in GASTROENTEROLOGY, W B SAUNDERS CO, Vol. 118, pp. A355 - A355, http://dx.doi.org/10.1016/S0016-5085(00)83524-6